| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2017 | CRL Charles River Laboratories International, Inc. | Molho Davide | Corporate Executive VP | Sell | 11,717 | $90.00 | $1,054,530.00 | -41.5% | |
| Mar 16, 2017 | CDNA Caredx, Inc. | Gagnon Neil | 10% Owner | Buy | 123,160 | $1.83 | $225,103.04 | +3.7% | |
| Mar 15, 2017 | TMO Thermo Fisher Scientific Inc. | Wilver Peter M | Exec. VP &Chief Admin Officer | Sell | 9,079 | $160.73 | $1,459,267.67 | -12.7% | |
| Mar 15, 2017 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chief Executive Officer | Sell | 20,000 | $158.60 | $3,172,000.00 | -6.5% | |
| Mar 15, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 1,800 | $8.03 | $14,453.50 | - | |
| Mar 14, 2017 | OPK Opko Health, Inc. | Logal Adam | Sr. Vice President, CFO | Sell | 112,975 | $8.07 | $911,674.36 | -41.2% | |
| Mar 13, 2017 | RVTY Revvity, Inc. | Goldberg Joel S58 | Please See Remarks | Sell | 30,710 | $55.45 | $1,702,930.92 | -33.5% | |
| Mar 13, 2017 | RVTY Revvity, Inc. | Wilson Frank Anders | Please See Remarks | Sell | 37,535 | $55.45 | $2,081,390.82 | -36.6% | |
| Mar 13, 2017 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 12,059 | $21.16 | $255,168.44 | -1.5% | |
| Mar 13, 2017 | EXAS Exact Sciences Corp | Lidgard Graham Peter | Chief Science Officer | Sell | 2,945 | $21.16 | $62,316.20 | -0.9% | |
| Mar 13, 2017 | NEO Neogenomics Inc | Brodie Steven G. | President, Pharma Services | Sell | 16,550 | $8.00 | $132,400.00 | -25.1% | |
| Mar 13, 2017 | EXAS Exact Sciences Corp | Coward D Scott77 | SVP And General Counsel | Sell | 1,983 | $21.16 | $41,960.28 | -3.8% | |
| Mar 13, 2017 | EXAS Exact Sciences Corp | Arora Maneesh | COO | Sell | 5,574 | $21.16 | $117,945.84 | -1.0% | |
| Mar 10, 2017 | CRL Charles River Laboratories International, Inc. | Johst David P | Corporate Executive VP | Sell | 34,593 | $89.06 | $3,080,931.70 | -0.6% | |
| Mar 10, 2017 | A Agilent Technologies, Inc. | Gonsalves Rodney65 | V.p., Corporate Controller | Sell | 8,496 | $52.05 | $442,216.80 | -31.9% | |
| Mar 10, 2017 | TMO Thermo Fisher Scientific Inc. | Wilver Peter M | Exec. VP &Chief Admin Officer | Sell | 9,987 | $158.18 | $1,579,743.66 | -12.2% | |
| Mar 10, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 1,800 | $7.97 | $14,345.00 | - | |
| Mar 10, 2017 | CRL Charles River Laboratories International, Inc. | Johst David P | Corporate Executive VP | Sell | 7,307 | $89.44 | $653,539.84 | -0.3% | |
| Mar 10, 2017 | CRL Charles River Laboratories International, Inc. | Molho Davide | Corporate Executive VP | Sell | 3,191 | $89.71 | $286,254.27 | -0.9% | |
| Mar 9, 2017 | PMDI Psychemedics Corp | Dyke James V. | Vice President - Sales | Sell | 10,513 | $20.56 | $216,147.28 | -38.1% | |
| Mar 9, 2017 | MTD Mettler Toledo International Inc/ | Kirk Simon | Head Of Product Inspection | Sell | 218 | $484.00 | $105,512.00 | -100% | |
| Mar 9, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 3,600 | $7.84 | $28,208.80 | - | |
| Mar 8, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 1,800 | $7.92 | $14,256.00 | - | |
| Mar 8, 2017 | TMO Thermo Fisher Scientific Inc. | Loewald Thomas W | Senior Vice President | Sell | 7,675 | $157.39 | $1,207,968.25 | -15.2% | |
| Mar 8, 2017 | MTD Mettler Toledo International Inc/ | Rauch Waldemar | Head Of Process Analytics | Sell | 1,250 | $484.00 | $605,000.00 | -28.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.